To evaluate the efficacy and safety of Eyetronix Flicker Glassess therapy in treating anisometropic amblyopia.
A total of 176 children with anisometropic amblyopia, aged 4 to 13 years, will randomize to receive patching or Eyetronix Flicker Glasses treatment in a 1:1 ratio.Eyetronix Flicker Glasses, a lightweight spectacle frame with liquid crystal lenses that provide direct square-wave alternating occlusion, will be used at a pre-programmed temporal frequency. Patching is a traditional treatment of amblyopia. The best corrected visual acuity, contrast sensitivity, binocular function,visual evoked potential and functional MRI will be measured at baseline and follow-up visits to assess the improvement of amblyopia.Feedback information from the questionnaires will be used to evaluate the compliance and adverse effects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
176
88 anisometropic amblyopia will be recruited to receive Eyetronix Flicker Glasses treatment.
88 anisometropic amblyopia will be recruited to receive patching treatment.
best corrected visual acuity
have an improvement of best corrected visual acuity in the amblyopic eyes
Time frame: 6 months
stereocuity
have an improvement of stereocuity in the amblyopic eyes
Time frame: 6 months
contrast sensitivity function
have an improvement of contrast sensitivity in the amblyopic eyes
Time frame: 6 months
visual evoked potential
P100 latency decrease and N75-P100 amplitude increase in the amblyopic eye.
Time frame: 6 months
functional MRI
the visual cortex activity have an improvement
Time frame: 6 months
best corrected visual acuity
have an improvement of best corrected visual acuity in the amblyopic eyes
Time frame: a year and a half
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.